Beacon Pharmaceuticals Market Cap

Beacon Pharmaceuticals has a market cap or net worth of 24.02 billion as of April 28, 2026. Its market cap has decreased by -18.05% in one year.

Market Cap

24.02B

Enterprise Value

30.68B

Revenue

14.78B

Ranking

n/a

PE Ratio

19.41

Stock Price

104.00

Market Cap Chart

Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 24.02B, an increase of 20.53%. That is a compound annual growth rate of 1.20%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	23.15B	-4.21%
Dec 30, 2025	24.16B	-23.03%
Dec 30, 2024	31.39B	-44.53%
Dec 28, 2023	56.60B	-14.34%
Dec 29, 2022	66.07B	17.50%
Dec 30, 2021	56.23B	210.46%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 27, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
The ACME Laboratories	16.12B
Unilever Consumer Care	39.89B
Asiatic Laboratories	13.05B
Renata	48.00B
Beximco Pharmaceuticals PLC.	52.42B
The IBN SINA Pharmaceutical Industry	9.84B
Navana Pharmaceuticals	6.44B
Orion Pharma	6.34B

Market Cap Rankings